Stuart McCracken

Sunderland Royal Hospital — United Kingdom

Medicine · Health Sciences

23h-index1.8kcitations89works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(49), Prostate Cancer Diagnosis and Treatment(27), Bladder and Urothelial Cancer Treatments(22), Ubiquitin and proteasome pathways(8), Urinary and Genital Oncology Studies(6)

Publications87 total

Suction Ureteral Access Sheaths During Flexible Ureteroscopy for Renal Stones: A Prospective Study and Cost Analysis
Cureus·2025Open Access
The Androgen Receptor and MYC synergise to modulate the synthesis of Siglec-7 ligands in prostate cancer
2025· 1 citedOpen Access
Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A randomised controlled trial assessing feasibility of randomisation for focal therapy in localised prostate cancer
European Urology Open Science·2025Open Access
Patients’ Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study
European Urology Oncology·2024· 4 citedOpen Access
Learning from myth to empower individuals to create longlasting narratives and personal branding in organizations
2024
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer
Journal of Clinical Investigation·2023· 10 citedOpen Access
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis
Journal of Medical Economics·2023· 19 citedOpen Access
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience
The Journal of Urology·2023· 9 cited
Supplementary Figures 1-6, Table 1 from FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth
2023Open Access
Data from FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth
2023Open Access
Data from FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth
2023Open Access
Supplementary Figures 1-6, Table 1 from FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth
2023Open Access
MP73-11 MEDIUM TERM OUTCOMES FOLLOWING PRIMARY FOCAL CRYOTHERAPY FOR LOCALISED PROSTATE CANCER IN 323 PATIENTS, A MULTI-INSTITUTIONAL OBSERVATIONAL STUDY OVER 10 YEARS
The Journal of Urology·2023
LBA03-07 IMPERIAL PROSTATE-4 COMPARATIVE HEALTHCARE RESEARCH OUTCOMES OF NOVEL SURGERY IN PROSTATE CANCER (IP4-CHRONOS): EARLY FEASIBILITY, SAFETY AND FUNCTIONAL OUTCOMES FROM A PILOT RCT
The Journal of Urology·2023· 1 cited
MP73-08 FOCAL ABLATIVE SALVAGE THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: A 10 YEAR EXPERIENCE OF ONCOLOGICAL AND SAFETY OUTCOMES IN 276 PATIENTS
The Journal of Urology·2023
Comparative healthcare research outcomes of novel Surgery in prostate cancer (IP4-CHRONOS): Pilot RCT assessing feasibility of randomization for focal therapy in localized prostate cancer.
Journal of Clinical Oncology·2022· 5 cited
MP55-06 FOCAL ABLATIVE SALVAGE THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: 6 YEAR ONCOLOGICAL AND SAFETY OUTCOMES
The Journal of Urology·2022
Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non–muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker
European Urology Focus·2022· 26 citedOpen Access
MRI-based nomogram for the prediction of prostate cancer diagnosis: A multi-centre validated patient–physician decision tool
Journal of Clinical Urology·2022· 8 citedOpen Access
Re-evaluating the diagnostic efficacy of PSA as a referral test to detect clinically significant prostate cancer in contemporary MRI-based image-guided biopsy pathways
Journal of Clinical Urology·2021· 9 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Tim Dudderidge(21), Craig Robson(17), Mathias Winkler(16), Hashim U. Ahmed(16), Taimur T. Shah(13), Manit Arya(11), Luke Gaughan(11), Deepika Reddy(11), Richard Hindley(10), Mark Emberton(9), Max Peters(8), Feargus Hosking‐Jervis(8), Raj Nigam(8), Jacqueline Stockley(7), Marieke van Son(7), Jaspal Virdi(7), Hing Y. Leung(6), Caroline M. Moore(6), David Eldred‐Evans(5), Raj Persad(5)